Diagnostic News and Research

RSS
IOVS journal publishes first global consensus report on MGD

IOVS journal publishes first global consensus report on MGD

Positive outcome from Orexo's OX51 initial pharmacokinetic trial to treat acute intensive pain

Positive outcome from Orexo's OX51 initial pharmacokinetic trial to treat acute intensive pain

Mitomics introduces new test to detect prostate cancer

Mitomics introduces new test to detect prostate cancer

Catheter-related bloodstream infections in children

Catheter-related bloodstream infections in children

Adeona reports $3,164,512 net revenue for 2010

Adeona reports $3,164,512 net revenue for 2010

Foundation for nationwide consensus on access to genetic information

Foundation for nationwide consensus on access to genetic information

Experts discuss about need for national colorectal cancer screening program at Capitol Hill

Experts discuss about need for national colorectal cancer screening program at Capitol Hill

Top-line results from Biomoda's CyPath pilot study against lung cancer

Top-line results from Biomoda's CyPath pilot study against lung cancer

Regular CT scans can cause secondary malignancies in older men with testicular cancer

Regular CT scans can cause secondary malignancies in older men with testicular cancer

KSB, SuperNova sign agreement to develop and commercialize Neopterin

KSB, SuperNova sign agreement to develop and commercialize Neopterin

Facebook depression - a new diagnostic entity

Facebook depression - a new diagnostic entity

Los Alamos National Lab, Biomagnetics to develop and commercialize IOBS system

Los Alamos National Lab, Biomagnetics to develop and commercialize IOBS system

New system can improve patient adherence to colonoscopy recommendations, reduce disparities

New system can improve patient adherence to colonoscopy recommendations, reduce disparities

Almac inaugurates new CLIA registered laboratory

Almac inaugurates new CLIA registered laboratory

Porter Adventist Hospital inaugurates new clinic to treat TIA

Porter Adventist Hospital inaugurates new clinic to treat TIA

Positive results from Vertex VX-770 Phase 3 trial against CF

Positive results from Vertex VX-770 Phase 3 trial against CF

Engineers create new microfluidic device that can detect cancer cells, HIV

Engineers create new microfluidic device that can detect cancer cells, HIV

Transgenomic discovers novel BLOCker-Sequencing technology

Transgenomic discovers novel BLOCker-Sequencing technology

Oral antioxidant formulation before medical imaging may minimize cell damage

Oral antioxidant formulation before medical imaging may minimize cell damage

FDA clears Access Scientific's POWERWAND catheter

FDA clears Access Scientific's POWERWAND catheter

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.